Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer. Issue 6 (July 2018)

• Record Type: Journal Article
• Authors: Tummers, Willemieke S.; Willmann, Juergen K.; Bonsing, Bert A.; Vahrmeijer, Alexander L.; Gambhir, Sanjiv S.; Swijnenburg, Rutger-Jan
• Is Part Of: Pancreas. Volume 47:Issue 6(2018)
• Publication Date: 2018-07
• Subjects: Molecular imaging -- tumor-specific imaging -- pancreatic cancer -- intraoperative; Pancreas -- Diseases -- Periodicals; Pancreas -- Periodicals; Neuroendocrine tumors -- Periodicals; 616.37005
• DOI: 10.1097/MPA.0000000000001075
• Languages: English
• ISSNs: 0885-3177

Abstract

Abstract : Abstract: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. To improve outcomes, there is a critical need for improved tools for detection, accurate staging, and resectability assessment. This could improve patient stratification for the most optimal primary treatment modality. Molecular imaging, used in combination with tumor-specific imaging agents, can improve established imaging methods for PDAC. These novel, tumor-specific imaging agents developed to target specific biomarkers have the potential to specifically differentiate between malignant and benign diseases, such as pancreatitis. When these agents are coupled to various types of labels, this type of molecular imaging can provide integrated diagnostic, noninvasive imaging of PDAC as well as image-guided pancreatic surgery. This review provides a detailed overview of the current clinical imaging applications, upcoming molecular imaging strategies for PDAC, and potential targets for imaging, with an emphasis on intraoperative imaging applications.